What Will It Take to Eliminate Pediatric HIV? Reaching WHO Target Rates of Mother-to-Child HIV Transmission in Zimbabwe: A Model-Based Analysis

English version České info

Background:
The World Health Organization (WHO) has called for the “virtual elimination” of pediatric HIV: a mother-to-child HIV transmission (MTCT) risk of less than 5%. We investigated uptake of prevention of MTCT (PMTCT) services, infant feeding recommendations, and specific drug regimens necessary to achieve this goal in Zimbabwe.

Methods and Findings:
We used a computer model to simulate a cohort of HIV-infected, pregnant/breastfeeding women (mean age, 24 y; mean CD4, 451/µl; breastfeeding duration, 12 mo). Three PMTCT regimens were evaluated: (1) single-dose nevirapine (sdNVP), (2) WHO 2010 guidelines' “Option A” (zidovudine in pregnancy, infant nevirapine throughout breastfeeding for women without advanced disease, lifelong combination antiretroviral therapy for women with advanced disease), and (3) WHO “Option B” (pregnancy/breastfeeding-limited combination antiretroviral drug regimens without advanced disease; lifelong antiretroviral therapy with advanced disease). We examined four levels of PMTCT uptake (proportion of pregnant women accessing and adhering to PMTCT services): reported rates in 2008 and 2009 (36% and 56%, respectively) and target goals in 2008 and 2009 (80% and 95%, respectively). The primary model outcome was MTCT risk at weaning.

The 2008 sdNVP-based National PMTCT Program led to a projected 12-mo MTCT risk of 20.3%. Improved uptake in 2009 reduced projected risk to 18.0%. If sdNVP were replaced by more effective regimens, with 2009 (56%) uptake, estimated MTCT risk would be 14.4% (Option A) or 13.4% (Option B). Even with 95% uptake of Option A or B, projected transmission risks (6.1%–7.7%) would exceed the WHO goal of less than 5%. Only if the lowest published transmission risks were used for each drug regimen, or breastfeeding duration were shortened, would MTCT risks at 95% uptake fall below 5%.

Conclusions:
Implementation of the WHO PMTCT guidelines must be accompanied by efforts to improve access to PMTCT services, retain women in care, and support medication adherence throughout pregnancy and breastfeeding, to approach the “virtual elimination” of pediatric HIV in Zimbabwe.

: Please see later in the article for the Editors' Summary

Vyšlo v časopise: What Will It Take to Eliminate Pediatric HIV? Reaching WHO Target Rates of Mother-to-Child HIV Transmission in Zimbabwe: A Model-Based Analysis. PLoS Med 9(1): e32767. doi:10.1371/journal.pmed.1001156
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001156

Souhrn

Zdroje

1. TubianaRLe ChenadecJRouziouxCMandelbrotLHamreneK 2010 Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load<500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1). Clin Infect Dis 50 585 596

2. United States Centers for Disease Control and Prevention 2010 Diagnoses of HIV infection by age. Available: http://www.cdc.gov/hiv/topics/surveillance/basic.htm#hivaidsage. Accessed 20 July 2011

3. World Health Organization 2010 Guidelines on HIV and infant feeding 2010: principles and recommendations for infant feeding in the context of HIV and a summary of evidence. Available: http://www.who.int/child_adolescent_health/documents/9789241599535/en/index.html. Accessed 20 July 2011

4. MofensonLTahaTLiQKumwendaJKafulafulaG 2009 Infant extended antiretroviral (ARV) prophylaxis is effective in preventing postnatal mother-to-child HIV transmission (MTCT) at all maternal CD4 counts [abstract]. 5th IAS Conference on HIV Pathogenesis; Treatment and Prevention; 19–22 July 2009; Cape Town, South Africa. Available: http://www.ias2009.org/pag/Abstracts.aspx?AID=1251. Accessed 20 July 2011

5. VyankandonderaJLuchtersSHassinkE 2003 Reducing risk of HIV-1 transmission from mother to infant through breastfeeding using antiretroviral prophylaxis in infants (SIMBA-study) [abstract]. 2nd IAS Conference on HIV Pathogenesis and Treatment; 13–16 July 2003; Paris, France

6. KilewoCKarlssonKNgarinaMMassaweALyamuyaE 2009 Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study. J Acquir Immune Defic Syndr 52 406 416

7. Kesho Bora Study Group 2010 Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts. J Acquir Immune Defic Syndr 54 533 541

8. ThiorILockmanSSmeatonLMShapiroRLWesterC 2006 Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 296 794 805

9. ShapiroRLHughesMDOgwuAKitchDLockmanS 2010 Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 362 2282 2294

10. ChaselaCSHudgensMGJamiesonDJKayiraDHosseinipourMC 2010 Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 362 2271 2281

11. PeltierCANdayisabaGFLepagePvan GriensvenJLeroyV 2009 Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 23 2415 2423

12. PalombiLMarazziMCVoetbergAMagidNA 2007 Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS 21 Suppl 4 S65 S71

13. Tonwe-GoldBEkoueviDKVihoIAmani-BosseCToureS 2007 Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach. PLoS Med 4 e257 doi:10.1371/journal.pmed.0040257

14. KumwendaNIHooverDRMofensonLMThigpenMCKafulafulaG 2008 Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 359 119 129

15. ThomasTKMasabaRBorkowfCBNdivoRZehC 2011 Triple-antiretroviral prophylaxis to prevent mother-to-child HIV transmission through breastfeeding–the Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med 8 e1001015 doi:10.1371/journal.pmed.1001015

16. MoszynskiP 2010 Global elimination of mother to child HIV transmission is now achievable, say agencies. BMJ 341 c5152

17. Global AIDS Alliance 2010 Campaign to End Pediatric HIV/AIDS. Available: http://www.endpediatricaids.net/index.php/1032. Accessed 20 July 2011

18. PR Newswire 2010 Elizabeth Glaser Pediatric AIDS Foundation releases toolkit for implementing new WHO recommendations on PMTCT and ARV treatment. Available: http://www.prnewswire.com/news-releases/elizabeth-glaser-pediatric-aids-foundation-releases-toolkit-for-implementing-new-who-recommendations-on-pmtct-and-arv-treatment-99104624.html. Accessed 20 July 2011

19. World Health Organization 2010 Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. Available: http://www.who.int/hiv/pub/2010progressreport/report/en/index.html. Accessed 20 July 2011

20. Joint United Nations Programme on HIV/AIDS 2009 Annual report 2009. Available: http://data.unaids.org/pub/Report/2010/2009_annual_report_en.pdf. Accessed February 21, 2011

21. World Health Organization 2010 Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. Available: http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf. Accessed 20 July 2011

22. BarkerPMMphatsweWRollinsN 2010 Antiretroviral drugs in the cupboard are not enough: the impact of health systems' performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr 56 e45 e48

23. Joint United Nations Programme on HIV/AIDS, United Nations Children's Fund, World Health Organization 2009 Children and AIDS: fourth stocktaking report, 2009. Available: http://www.unicef.org/publications/files/Children_and_AIDS_Fourth_Stocktaking_Report_EN_110609.pdf. Accessed 6 December 2011

24. StringerEMEkoueviDKCoetzeeDTihPMCreekTL 2010 Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA 304 293 302

25. StringerEMChiBHChintuNCreekTLEkoueviDK 2008 Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. Bull World Health Organ 86 57 62

26. MarstonMBecquetRZabaBMoultonLHGrayG 2011 Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol 40 385 396

27. PerezFOrne-GliemannJMukotekwaTMillerAGlenshawM 2004 Prevention of mother to child transmission of HIV: evaluation of a pilot programme in a district hospital in rural Zimbabwe. BMJ 329 1147 1150

28. CiaranelloALSeageGRFreedbergKAWeinsteinMCLockmanS 2008 Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity. AIDS 22 2359 2369

29. CiaranelloALPerezFMaruvaMChuJEnglesmannB 2011 WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers. PLoS ONE 6 e20224 doi:10.1371/journal.pone.0020224

30. GoldieSJYazdanpanahYLosinaEWeinsteinMCAnglaretX 2006 Cost-effectiveness of HIV treatment in resource-poor settings—the case of Côte d'Ivoire. N Engl J Med 355 1141 1153

31. WalenskyRPWolfLLWoodRFofanaMOFreedbergKA 2009 When to start antiretroviral therapy in resource-limited settings. Ann Intern Med 151 157 166

32. CiaranelloALockmanSFreedbergKAHughesMChuJ 2011 First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS 25 479 492

33. National Drug and Therapeutics Policy Advisory Committee & AIDS and TB Unit 2009 Guidelines for antiretroviral therapy in Zimbabwe Harare Zimbabwe Ministry of Health and Child Welfare

34. World Bank 2011 Population, total. Available: http://data.worldbank.org/indicator/SP.POP.TOTL. Accessed 20 July 2011

35. Index Mundi 2011 Zimbabwe birth rate. Available: http://www.indexmundi.com/zimbabwe/birth_rate.html. Accessed 20 July 2011

36. Zimbabwe Ministry of Health and Child Welfare 2009 National HIV estimates Harare Zimbabwe Ministry of Health and Child Welfare

37. World Health Organization 2009 Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report. Available: http://www.who.int/hiv/pub/tuapr_2009_en.pdf. Accessed 20 July 2011

38. WalenskyRPWoodRCiaranelloALPaltielADLorenzanaSB 2010 Scaling up the 2010 World Health Organization HIV treatment guidelines in resource-limited settings: a model-based analysis. PLoS Med 7 e1000382 doi:10.1371/journal.pmed.1000382

39. NewellMLCoovadiaHCortina-BorjaMRollinsNGaillardP 2004 Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 364 1236 1243

40. CrampinACFloydSGlynnJRMadiseNNyondoA 2003 The long-term impact of HIV and orphanhood on the mortality and physical well-being of children in rural Malawi. AIDS 17 389 397

41. NakiyingiJSBracherMWhitworthJARuberantwariABusingyeJ 2003 Child survival in relation to mother's HIV infection and survival: evidence from a Ugandan cohort study. AIDS 17 1827 1834

42. ZabaBWhitworthJMarstonMNakiyingiJRuberantwariA 2005 HIV and mortality of mothers and children: evidence from cohort studies in Uganda, Tanzania, and Malawi. Epidemiology 16 275 280

43. AhouaLAyikoruHGnauckKOdaruGOdarE 2010 Evaluation of a 5-year programme to prevent mother-to-child transmission of HIV infection in Northern Uganda. J Trop Pediatr 56 43 52

44. ManziMZachariahRTeckRBuhendwaLKazimaJ 2005 High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health 10 1242 1250

45. RamdhialRRamkissoonA 2009 Integration of HAART into public sector antenatal care services in a high prevalence HIV setting in South Africa [abstract]. 5th IAS Conference on HIV Pathogenesis and Treatment; 19–22 July 2009; Cape Town, South Africa. Available: http://www.iasociety.org/Default.aspx?pageId=12&abstractId=200722054. Accessed 20 July 2011

46. SrikewalJMoodleyDMsweliL 2009 The impact of an integrated health system on the delivery of PMTCT services in Kwazulu Natal [abstract]. 5th IAS Conference on HIV Pathogenesis; Treatment and Prevention; 19–22 July 2009; Cape Town, South Africa. Available: http://www.ias2009.org/pag/Abstracts.aspx?AID=3432. Accessed 20 July 2011

47. ChiBHChintuNLeeAStringerEMSinkalaM 2007 Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia. J Acquir Immune Defic Syndr 45 125 127

48. KaplanROrrellCZwaneEBekkerLGWoodR 2008 Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS 22 1679 1681

49. StinsonKBoulleACoetzeeDAbramsEJMyerL 2010 Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Trop Med Int Health 15 825 832

50. KumwendaJMatayaRKumwendaNKafulafulaGLiQ 2009 Coverage of highly active antiretroviral therapy (HAART) among postpartum women in Malawi [abstract]. 5th IAS Conference on HIV Pathogenesis; Treatment and Prevention; 19–22 July 2009; Cape Town, South Africa. Available: http://www.ias2009.org/pag/Abstracts.aspx?AID=1938. Accessed 20 July 2011

51. BrinkhofMWDabisFMyerLBangsbergDRBoulleA 2008 Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86 559 567

52. GengEHBangsbergDRMusinguziNEmenyonuNBwanaMB 2010 Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 53 405 411

53. AmuronBNamaraGBirungiJNabiryoCLevinJ 2009 Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda. BMC Public Health 9 290

54. MyerLCarterRJKatyalMToroPEl-SadrWM 2010 Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study. PLoS Med 7 e1000229 doi:10.1371/journal.pmed.1000229

55. RosenSFoxMPGillCJ 2007 Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4 e298 doi:10.1371/journal.pmed.0040298

56. ToroPLKatyalMCarterRJMyerLEl-SadrWM 2010 Initiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention. AIDS 24 515 524

57. Ministry of Health and Child Welfare 2008 Maternal and Perinatal Mortality Study 2007 Harare Zimbabwe Ministry of Health and Child Welfare

58. IliffPJPiwozEGTavengwaNVZunguzaCDMarindaET 2005 Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 19 699 708

59. FawziWMsamangaGSpiegelmanDRenjifoBBangH 2002 Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 31 331 338

60. ChigwederePSeageGRLeeTHEssexM 2008 Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials. AIDS Res Hum Retroviruses 24 827 837

61. CoutsoudisAPillayKKuhnLSpoonerETsaiWY 2001 Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS 15 379 387

62. DabisFBequetLEkoueviDKVihoIRouetF 2005 Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS 19 309 318

63. NduatiRJohnGMbori-NgachaDRichardsonBOverbaughJ 2000 Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283 1167 1174

64. Petra Study Team 2002 Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 359 1178 1186

65. GuayLAMusokePFlemingTBagendaDAllenM 1999 Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354 795 802

66. ThistlePSpitzerRFGlazierRHPilonRArbessG 2007 A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe. Clin Infect Dis 44 111 119

67. Kesho Bora Study Group 2011 Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect Dis 11 171 180

68. KuhnLSinkalaMKankasaCSemrauKKasondeP 2007 High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission. PLoS ONE 2 e1363 doi:10.1371/journal.pone.0001363

69. LeroyVNewellMLDabisFPeckhamCVan de PerreP 1998 International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV. Lancet 352 597 600

70. LallemantMJourdainGLe CoeurSMaryJYNgo-Giang-HuongN 2004 Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 351 217 228

71. CooperERCharuratMMofensonLHansonICPittJ 2002 Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 29 484 494

72. DorenbaumACunninghamCKGelberRDCulnaneMMofensonL 2002 Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 288 189 198

73. CoutsoudisADabisFFawziWGaillardPHaverkampG 2004 Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 189 2154 2166

74. Department of Economic and Social Affairs 2009 World population prospects: the 2008 revision New York United Nations Available: http://www.un.org/esa/population/publications/wpp2008/wpp2008_highlights.pdf. Accessed 20 July 2011

75. MarindaEHumphreyJHIliffPJMutasaKNathooKJ 2007 Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 26 519 526

76. Kids' ART-LINC Collaboration 2008 Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in sub-Saharan Africa. J Acquir Immune Defic Syndr 49 523 531

77. SutcliffeCGvan DijkJHBoltonCPersaudDMossWJ 2008 Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis 8 477 489

78. LeroyVSakarovitchCCortina-BorjaMMcIntyreJCoovadiaH 2005 Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS 19 1865 1875

79. KuhnLAldrovandiGMSinkalaMKankasaCMwiyaM 2010 Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to- child HIV transmission. AIDS 24 1374 1377

80. CarterRJDuganKEl-SadrWMMyerLOtienoJ 2010 CD4+ cell count testing more effective than HIV disease clinical staging in identifying pregnant and postpartum women eligible for antiretroviral therapy in resource-limited settings. J Acquir Immune Defic Syndr 55 404 410

81. MahyMStoverJKiraguKHayashiCAkwaraP 2010 What will it take to achieve virtual elimination of mother-to-child transmission of HIV? An assessment of current progress and future needs. Sex Transm Infect 86 Suppl 2 ii48 ii55

82. World Health Organization 2005 The 3 by 5 initiative. Available: http://www.who.int/3by5/en/. Accessed 20 July 2011

83. KramarenkoVEngstromLVerdierGFernandezGOppersSE 2010 Zimbabwe: challenges and policy options after hyperinflation Washington (District of Columbia) International Monetary Fund Available: http://www.imf.org/external/pubs/ft/dp/2010/afr1003.pdf. Accessed 20 July 2011

84. BedriAGudettaBIsehakAKumbiSLulsegedS 2008 Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 372 300 313

85. National Institutes of Health IMPAACT Trial Network 2010 IMPAACT P1077: the PROMISE Study (Promoting Maternal and Infant Survival Everywhere)—synopsis. Available: http://www.docstoc.com/docs/42000343/IMPAACT-P1077_-PROMISE. Accessed 20 July 2011

86. GengEHEmenyonuNBwanaMBGliddenDVMartinJN 2008 Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300 506 507

87. HuttonGBartramJ 2008 Global costs of attaining the Millennium Development Goal for water supply and sanitation. Bull World Health Organ 86 13 19

88. MofensonLM 2010 Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection. Clin Infect Dis 50 Suppl 3 S130 S148

89. YounglesonMSNkurunzizaPJenningsKArendseJMateKS 2011 Improving a mother to child HIV transmission programme through health system redesign: quality improvement, protocol adjustment and resource addition. PLoS ONE 5 e13891 doi:10.1371/journal.pone.0013891

90. LockmanSHughesMDMcIntyreJZhengYChipatoT 2010 Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med 363 1499 1509

91. PalumboPLindseyJCHughesMDCottonMFBobatR 2010 Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med 363 1510 1520

92. MellorsJWMunozAGiorgiJVMargolickJBTassoniCJ 1997 Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126 946 954

93. FawziWWMsamangaGIHunterDRenjifoBAntelmanG 2002 Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS 16 1935 1944

94. LeroyVKaronJMAlioumAEkpiniERMedaN 2002 Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 16 631 641

95. ThistlePGottesmanMPilonRGlazierRHArbessG 2004 A randomized control trial of an ultra-short zidovudine regimen in the prevention of perinatal HIV transmission in rural Zimbabwe. Cent Afr J Med 50 79 84

96. ConnorEMSperlingRSGelberRKiselevPScottG 1994 Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331 1173 1180

97. FassinouPElengaNRouetFLaguideRKouakoussuiKA 2004 Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire. AIDS 18 1905 1913